3-IB-MECA,
IB-MECA,
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,
N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide,
N(6)-IBAMU,
IB-MECA,
152918-18-8,
piclidenoson,
CF-101,
3-IB-Meca,
N(6)-Ibamu,
CF 101,
N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,
Cf101,
UNII-30679UMI0N,
N(6)-(3-Iodobenzyl)adenosine-5'-N-methyluronamide,
1-Deoxy-1-(6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-N-methyl-beta-D-ribofuranuronamide,
CHEMBL119709,
CHEBI:73286,
30679UMI0N,
RPR-113090,
3-iodobenzyl-5'-N-methylcarboxamidoadenosine,
N(6)-(3-iodo-benzyl)adenosine-5'-N-methyluronamide,
(2S,3S,4R,5R)-3,4-dihydroxy-5-(6-((3-iodobenzyl)amino)-9H-purin-9-yl)-N-methyltetrahydrofuran-2-carboxamide,
(2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide,
(2S,3S,4R,5R)-5-{6-[(3-iodobenzyl)amino]-9H-purin-9-yl}-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide,
beta-D-Ribofuranuronamide, 1-deoxy-1-(6-(((3-iodophenyl)methyl)amo)-9H-purin-9-yl)-N-methyl-,
1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9h-purin-9-yl]-n-methyl-beta-d-ribofuranuronamide,
IBMECA,
Piclidenoson [USAN],
Piclidenoson (USAN/INN),
AC1L3X3V,
GTPL422,
MLS002153391,
SCHEMBL465039,
REGID_for_CID_123683,
CTK8E8477,
AOB5361,
DTXSID50165158,
HUJXGQILHAUCCV-MOROJQBDSA-N,
HMS2234I04,
HMS3676E09,
3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide,
CF-101; IB-MECA; Piclidenoson,
EX-A2514,
ZINC3811810,
BDBM50118812,
MFCD00671785,
SI-615,
AKOS024456363,
API0005162,
CS-5048,
DB05511,
SB16936,
IB-MECA, solid, >=98% (HPLC),
NCGC00024978-02,
NCGC00024978-03,
NCGC00024978-04,
NCGC00024978-05,
AN-16662,
AS-16876,
HY-13591,
SC-41757,
SMR001230772,
LS-184434,
RT-013304,
D10971,
N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide,
J-008958,
N6-(3-iodobenzyl)-5''-N-methylcarboxamidoadenosine,
(N-6-(3-iodobenzyl)adenosine-5''-N-methyluronamide,
Adenosine, N(6)-[3-iodobenzyl]-4'-methylcarbamoyl-4'-dehydroxymethyl-,
N6-(3-Iodobenzyl)adenosine-5 inverted exclamation marka-N-methyluronamide,
1-Deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-?-D-ribofuranuronamide,
(2R,3R,4S,5S)-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide;CF 101,
(2S,3S,4R,5R)-3,4-dihydroxy-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-N-methyltetrahydrofuran-2-carboxamide,
(2S,3S,4R,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide,
(2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyl-tetrahydrofuran-2-carboxamide,
(2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide,
(3R,4S,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide,
(3S,4R,5R)-3,4-Dihydroxy-5-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-2-carboxylic acid methylamide,
1-Deoxy-1-[6-[((3-Iodophenyl)methyl)amino]-9H-purin-9-yl]-N-methyl-|A-D-ribofuranuronamide,
b-D-Ribofuranuronamide,1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-,
D03VTU,
D0Y6ZK,
C18H19IN6O4,
C18-H19-I-N6-O4,
CID123683,
ACN-038405,
C084956,
C478920,
1-deoxy-1-(6-(((iodophenyl)methyl)amino)9H-purine-9-yl)-N-methyl-(D-ribofuranuronamide),